Global orthopedic sales totaled $59 billion in 2023, an increase of 6.5% compared to 2022. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
The Numbers
Stay up to date on the orthopedic market’s 2Q performance in 2024 as we update this post with company sales data and industry developments.
The U.S. remains the world’s largest orthopedic market by revenue, but companies see significant opportunities for international growth.
Funds will accelerate the U.S. launch of ABANZA’s soft tissue fixation line, including the WasherCap and WasherCap Mini.
September 5, 2024
,
The company drove mid-single-digit sales growth in the first quarter of its 2025 fiscal year driven by pull through from the AiBLE ecosystem.
August 22, 2024
,
The company grew in the mid-single digits during the second quarter of 2024 as it looks to expand its presence in the bunion market.
August 16, 2024
,
While orthopedic growth rates slowed in the first half of 2024, the market’s volume and demand remain healthy.
August 15, 2024
,
The company grew 20% in the second quarter of 2024 driven by an expanding portfolio and active surgeon base.
August 15, 2024
,
The top players in the trauma space are growing in line with historical averages despite a choppy operating environment in recent years.
October 10, 2024
,
Consolidation, enabling technology and implant breakthroughs are creating long term change in the spine market.
September 19, 2024
,
In part, funds will support enhanced capabilities of the AI-driven augmented reality intraoperative data platform, ADVISE.
September 17, 2024
,
The top ten most acquisitive orthopedic companies since 2016 are more focused on technology than the rest of the market.
September 11, 2024
,
Funds will accelerate the U.S. launch of ABANZA’s soft tissue fixation line, including the WasherCap and WasherCap Mini.
September 5, 2024
,
The company drove mid-single-digit sales growth in the first quarter of its 2025 fiscal year driven by pull through from the AiBLE ecosystem.
August 22, 2024
,
The company grew in the mid-single digits during the second quarter of 2024 as it looks to expand its presence in the bunion market.
August 16, 2024
,
While orthopedic growth rates slowed in the first half of 2024, the market’s volume and demand remain healthy.
August 15, 2024
,
The company grew 20% in the second quarter of 2024 driven by an expanding portfolio and active surgeon base.
August 15, 2024
,
Stay up to date on the orthopedic market’s 2Q performance in 2024 as we update this post with company sales data and industry developments.
